Article Details

Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK ...

Retrieved on: 2022-11-11 02:10:24

Tags for this article:

Click the tags to see associated articles and topics

Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK .... View article details on hiswai:

Excerpt

... monoclonal antibodies in multiple preclinical models of cancer. ... candidate AB-101 combined with therapeutic monoclonal antibodies was seen ...

Article found on: www.bdtonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up